Brief: Bionano Announces First Study Using Ogm To Discover Structural Variants With Potential Relevance To Genetic Diagnosis Of Mrkh Syndrome, A Syndrome Impacting Reproductive System Development In 1 In 4,500 Females
22/03/2023 12:12
March 22 (Reuters) - Bionano Genomics Inc BNGO.O :
* BIONANO ANNOUNCES FIRST STUDY USING OGM TO DISCOVER
STRUCTURAL
VARIANTS WITH POTENTIAL RELEVANCE TO GENETIC DIAGNOSIS OF MRKH
SYNDROME, A SYNDROME IMPACTING REPRODUCTIVE SYSTEM DEVELOPMENT
IN 1 IN 4,500 FEMALES
Source text for Eikon: ID:nGNXcVNzd
Further company coverage: BNGO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt